Literature DB >> 3680078

Biliary penetration of cefbuperazone in the presence and absence of obstructive jaundice.

H Tanaka1, H Nishino, T Sawada, N Kawaguchi, T Azuma, Y Yoshii, K Satake.   

Abstract

In thirteen patients with normal liver function, the mean concentrations of cefbuperazone in hepatic bile, gall bladder bile and gallbladder tissue 30 min after injection were 1134.8 +/- 36.8 (mean +/- S.E.M.) mg/l, 6.6 +/- 3.0 mg/l and 26.1 +/- 7.6 mg/l, respectively. In patients with obstructive jaundice, cefbuperazone concentrations in bile were 99 +/- 29.2 mg/l (mean +/- S.E.M.) 1 h post-dose and decreased to 13.9 +/- 5.1 mg/l 6 h post-dose. In both groups of patients biliary concentrations of cefbuperazone were higher than the MICs of most organisms causing biliary infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3680078     DOI: 10.1093/jac/20.3.417

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  1 in total

1.  Biliary and renal excretions of cefpiramide in Eisai hyperbilirubinemic rats.

Authors:  I Muraoka; T Hasegawa; M Nadai; L Wang; S Haghgoo; O Tagaya; T Nabeshima
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.